Giuseppe Licci

4PUBLICATIONS
6CO-AUTHORS
Characterisation of biological macromoleculesNanomedicineRegenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 23, 2025
Sustained Efficacy and Low Rate of Adverse Events of Dupilumab in Type-2 CRSwNP Over 48 Months.

Pietro Orlando, Giuseppe Licci, Gennaro Illiano

|Oct 15, 2024
Effects of Mepolizumab in the treatment of type 2 CRSwNP: a real-life clinical study.

Pietro Orlando, Emanuele Vivarelli, Alberto Minzoni

|Nov 01, 2023
Effectiveness of dupilumab versus endoscopic sinus surgery for the treatment of type-2 chronic rhinosinusitis with nasal polyps: a preliminary report.

Pietro Orlando, Giuseppe Licci, Donald Kuitche

|Feb 11, 2023
The Same-Up-Down Staging System for Recurrent Early Glottic Cancer.

Giuseppe Licci, Luca Giovanni Locatello, Giandomenico Maggiore

Pageof 1

Frequent Collaborators

3 joint publications

Giandomenico Maggiore

2 joint publications

Oreste Gallo

2 joint publications

Pietro Orlando

1 joint publications

Luca Giovanni Locatello